- Type
- Plasticizer
- How serious
- High severity
- Evidence
- Strong evidence
Why it is flagged
Anti-androgenic in animal and human studies; restricted in cosmetics and children's articles across the EU. For PCOS the evidence is mixed: meta-analyses link DEHP to insulin resistance and one study found more of it in the ovarian follicles of women with PCOS, but studies comparing women with and without PCOS disagree.
Health topics it bears on
Sources
- Cosmetic Ingredient Hotlist Health Canada, 2025
- Screening assessment - Phthalate substance grouping Environment and Climate Change Canada and Health Canada, 2020
- Phthalates Health Canada, 2020
- Environmental exposure to selected non-persistent endocrine disrupting chemicals and polycystic ovary syndrome: a systematic review International Journal of Occupational Medicine and Environmental Health (Ozga and Jurewicz), 2025
- An Umbrella Review of Meta-Analyses Evaluating Associations between Human Health and Exposure to Major Classes of Plastic-Associated Chemicals Annals of Global Health (Symeonides et al.), 2024
- Prenatal Exposure to Endocrine Disruptors: A Developmental Etiology for Polycystic Ovary Syndrome Reproductive Sciences (Hewlett et al.), 2017
Also listed as
dehp, bis(2-ethylhexyl) phthalate